Present and Future Treatment of Mycobacteria

Author(s): J. C. Rodriguez , I. Escribano , R. A. Gomez , E. Garcia Pachon , A. Navarro , G. Royo .

Journal Name: Anti-Infective Agents in Medicinal Chemistry

Volume 7 , Issue 1 , 2008

Abstract:

To review the treatments currently used to treat mycobacteria (latent tuberculosis, clinical tuberculosis, infections due to mycobacteria), focussing on : Doses administered and duration of treatment Levels reached in different body tissues in relation to the chemical characteristics of the drugs The relation between these data and the microbiological parameters of each microorganism To review the above parameters for the new groups of drugs being investigated for treatment of the three pathologies. a. fluorquinolones b. macrolides c. rifampicins d. oxazolidinones e. tetracyclines f.- other drugs undergoing investigation

Keywords: Mycobacterium tuberculosis, rifampicin resistance, fluoroquinolones, Mycobacterium avium, M-DCMG conjugate

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 1
Year: 2008
Page: [1 - 11]
Pages: 11
DOI: 10.2174/187152108783329816

Article Metrics

PDF: 14